For most of modern history, the average lipstick has lived under older law than the average airplane. The rules governing cosmetics safety in the United States were written into the Federal Food, Drug, and Cosmetic Act of 1938, and for eighty-four years they barely moved. The agency responsible could inspect, could seize, could warn, but it could not compel the basic bookkeeping that a corner bakery would consider routine. Then, at the end of 2022, tucked into a spending bill, the industry’s regulatory floor was rebuilt almost overnight.
The Modernization of Cosmetics Regulation Act, known as MoCRA, is the most significant expansion of federal cosmetics authority since that 1938 starting line. Its consequences reach every shelf: a registration system for manufacturing facilities, a listing requirement for products, mandatory reporting of serious adverse events, and, for the first time, the power to suspend a facility’s registration outright. For an industry long described as self-policed, the vocabulary has changed, and so has the shopping experience of anyone who knows what the new words mean.
What actually changed in 2022
The old system rested on a simple bargain. A cosmetic firm did not need approval before selling a product, and the agency acted only after problems surfaced, working from voluntary reports and complaint letters. The new system keeps the no-preapproval tradition, cosmetics are still not cleared before market the way drugs are, but it builds an administrative spine underneath it. Facilities that manufacture or process cosmetics for United States sale must now register with the Food and Drug Administration, and the products themselves must be listed, each one tied to its maker through a public record.
The agency’s MoCRA overview describes the machinery in the flat language of implementation, and the flatness is the point. Registration suspension, inspections, records, recalls framed as responsibilities rather than favors: these are ordinary powers that ordinary regulated industries have taken for granted for decades. Cosmetics simply joined the administrative century eighty-four years late.
A register, and teeth
The most consequential clause is the shortest to state. Under the new law, the FDA can suspend a facility’s registration when it determines there is a reasonable probability that cosmetics from that facility would cause serious adverse health consequences. Once a registration is suspended, shipping cosmetics from that facility becomes a prohibited act, which is the statutory way of saying the shipments become illegal rather than merely discouraged.
This converts the enforcement dynamic. Under the 1938 framework, a serious problem led to negotiation, warning letters, and eventually seizure of specific batches. Under the current one, a facility itself can be switched off. An industry that once computed the cost of a recall against the cost of a lawsuit now computes against the cost of losing its license to ship at all, a different arithmetic entirely.
July 2024, the deadline that held
The law’s registration and listing requirements carried a practical deadline. Enforcement of the facility registration and product listing mandates began on July 1, 2024, after a six-month extension the agency used to build capacity and educate an industry with no prior experience of the paperwork. Registrations renew on a two-year cycle, which means the first cohort of cosmetics facilities faced its second filing season in 2026.
The submissions run through a purpose-built portal, Cosmetics Direct, launched in late 2023 and updated as recently as February 2026 with new tutorials and form guidance. A government portal sounds like the least glamorous part of the reform, but portals are where laws become habits. Every listing that flows through the system attaches a product to a facility, a facility to a responsibility, and a responsibility to a record that outlasts any marketing cycle.
| Requirement | Who it covers | Key dates |
| Facility registration | Manufacturers and processors for US sale | Enforcement from July 1, 2024 |
| Product listing | Cosmetic products tied to registered facilities | Same deadline, updated with changes |
| Registration renewal | All registered facilities | Every two years |
| Adverse event records | Responsible persons for each product | Ongoing since the law took effect |
The small business line
Not every workshop is in the system. The registration and listing requirements exempt certain small businesses, a carve-out that recognizes the difference between an industrial filler and an independent formulator working in a studio. The exemption is real but ragged at the edges: it does not extend to every product category, and formulas near the drug boundary, such as products with sunscreen claims, sit outside its protection regardless of the size of the maker.
For a shopper, the small business line explains a quirk of the new landscape. Two otherwise similar products may carry very different regulatory footprints because one comes from a large registered facility and the other from an exempt studio. Neither is automatically safer, and the exemption is a burden calculation, not a quality judgment. But the consumer who understands the distinction also understands what the new records can and cannot answer, which is most of the battle with any regulatory database.
Reading a brand differently
The practical effect on the beauty counter is quieter than the statute suggests. Nothing about MoCRA changes what a jar may promise, and ingredient marketing will keep running ahead of ingredient science as it always has. What changed is the infrastructure beneath the promises: a serious reaction now generates a mandatory record, a facility with a pattern of problems can be switched off, and the gap between the brand on the label and the plant that filled the jar is narrower than it has ever been.
There is a second-order effect that is easier to miss. For decades, the absence of records shaped how beauty journalism worked, because a writer investigating a reaction or a contaminated batch had almost nothing official to consult, only company statements and court filings. A registry changes the raw material of accountability itself. When a product is listed, its responsible person is named in a government system, and the questions a reviewer or a reporter asks can be answered by the record rather than by the marketing department. Coverage gets sharper because the paper trail finally exists, and sharper coverage does work that no inspection schedule can.
Ingredient-focused coverage has started to reflect the shift. Beauty guides such as the product breakdowns at Arlene Persaud, which walk readers through labels and formulations claim by claim, now write in a world where those labels sit on top of a federal registry rather than on top of a void. The smartest reading treats the two layers as complements: the guide explains what the ingredient list says, and the registry, when it is consulted, confirms who stands behind it. Neither layer replaces the other, and a shopper who uses both is harder to mislead than any registry or any review could manage alone.
The 1938 law was written for an industry of cold creams and talc, and it served, unchanged, through the entire rise of modern cosmetic chemistry, global supply chains, and the ten-step routine. Its replacement arrived as an amendment to a budget bill, which is an unromantic birth for a reform this size. But the direction it set is unmistakable, and the second renewal season in 2026 is the proof: the register is no longer new, it is simply how the industry is run. Eighty-four years of tradition ended not with a crisis but with a form, and the form, unusually, turned out to be the story.
